StockData
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc. (CTXR) stock

CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.53−0.01 (-1.40%)

Close on Nov 16, 2026Market cap $14.48MP/E –Yield –

Citius Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

Citius Pharmaceuticals's cash was $17.01M at Jun 30, 2026. For fiscal 2025 it was $4.25M, up 30.8% from the year before. Over ten years it grew 181.7% a year on average. The highest annual figure on record is $70.07M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Sep 30, 2025$4.25M+30.8%
FY2024Sep 30, 2024$3.25M-87.7%
FY2023Sep 30, 2023$26.48M-36.5%
FY2022Sep 30, 2022$41.71M-40.5%
FY2021Sep 30, 2021$70.07M+405.6%
FY2020Sep 30, 2020$13.86M+75.6%
FY2019Sep 30, 2019$7.89M-14.0%
FY2018Sep 30, 2018$9.18M+186.6%
FY2017Sep 30, 2017$3.20M+988.5%
FY2016Sep 30, 2016$294.35K+217937.8%
FY2012Sep 30, 2012$135-36.3%
FY2011Sep 30, 2011$212–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$17.01M+179.3%
Q2 FY2026CQ1 2026Mar 31, 2026$4.59M+17280.4%
Q1 FY2026CQ4 2025Dec 31, 2025$7.72M+601.9%
Q4 FY2025CQ3 2025Sep 30, 2025$4.25M+30.8%
Q3 FY2025CQ2 2025Jun 30, 2025$6.09M-66.0%
Q2 FY2025CQ1 2025Mar 31, 2025$26.41K-99.8%
Q1 FY2025CQ4 2024Dec 31, 2024$1.10M-94.6%
Q4 FY2024CQ3 2024Sep 30, 2024$3.25M-87.7%
Q3 FY2024CQ2 2024Jun 30, 2024$17.91M-46.2%
Q2 FY2024CQ1 2024Mar 31, 2024$12.56M-66.0%
Q1 FY2024CQ4 2023Dec 31, 2023$20.35M-51.2%
Q4 FY2023CQ3 2023Sep 30, 2023$26.48M-44.9%
Q3 FY2023CQ2 2023Jun 30, 2023$33.28M-40.3%
Q1 FY2023CQ4 2022Dec 31, 2022$36.89M-43.6%
Q4 FY2022CQ3 2022Sep 30, 2022$41.71M-40.5%
Q3 FY2022CQ2 2022Jun 30, 2022$48.04M-58.5%
Q2 FY2022CQ1 2022Mar 31, 2022$55.76M-46.2%
Q1 FY2022CQ4 2021Dec 31, 2021$65.42M+1423.0%
Q4 FY2021CQ3 2021Sep 30, 2021$70.07M+405.6%
Q3 FY2021CQ2 2021Jun 30, 2021$115.66M+1258.0%
Q2 FY2021CQ1 2021Mar 31, 2021$103.70M+2289.8%
Q1 FY2021CQ4 2020Dec 31, 2020$4.30M+54.5%
Q4 FY2020CQ3 2020Sep 30, 2020$13.86M+75.6%
Q3 FY2020CQ2 2020Jun 30, 2020$8.52M+88.8%
Q2 FY2020CQ1 2020Mar 31, 2020$4.34M+35.6%
Q1 FY2020CQ4 2019Dec 31, 2019$2.78M-60.5%
Q4 FY2019CQ3 2019Sep 30, 2019$7.89M-14.0%
Q3 FY2019CQ2 2019Jun 30, 2019$4.51M+63.3%
Q2 FY2019CQ1 2019Mar 31, 2019$3.20M-36.1%
Q1 FY2019CQ4 2018Dec 31, 2018$7.04M-4.5%
Q4 FY2018CQ3 2018Sep 30, 2018$9.18M+186.6%
Q3 FY2018CQ2 2018Jun 30, 2018$2.76M+1289.7%
Q2 FY2018CQ1 2018Mar 31, 2018$5.01M+8094.8%
Q1 FY2018CQ4 2017Dec 31, 2017$7.37M+15661.5%
Q4 FY2017CQ3 2017Sep 30, 2017$3.20M+988.5%
Q3 FY2017CQ2 2017Jun 30, 2017$198.73K-87.8%
Q2 FY2017CQ1 2017Mar 31, 2017$61.11K–
Q1 FY2017CQ4 2016Dec 31, 2016$46.76K–
Q4 FY2016CQ3 2016Sep 30, 2016$294.35K–
Q3 FY2016CQ2 2016Jun 30, 2016$1.63M–

More Citius Pharmaceuticals figures

See a number that looks wrong?